Definitive Healthcare Corp. cash flow to debt ratio of 31.15% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Definitive Healthcare Corp.'s free cash flow has decreased 19.18% from $45.85M last year to $37.06M, signaling decreasing performance

Definitive Healthcare Corp.'s debt to equity ratio is 0.03, which means that the company's assets are healthy financed, signaling financial stability.

Definitive Healthcare Corp.'s debt has decreased relative to shareholder equity from 0.57 last year to 0.03 today, signaling strengthened financials

Definitive Healthcare Corp. has a net cash position, so leverage is healthy.

Definitive Healthcare Corp.'s interest coverage ratio of 22.02 indicates that earnings with good margin can cover interest payments on company debt

Definitive Healthcare Corp.'s profit margin has increased (-55.88%) in the last year from -163.81% to -72.28%, signaling increasing performance

Definitive Healthcare Corp.'s short-term assets of $257.61M exceed its short-term liabilities of $156.79M

Definitive Healthcare Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Definitive Healthcare Corp.'s return on equity of -74.75%, is lower than 15.00%, indicating bad performance

Definitive Healthcare Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Definitive Healthcare Corp. has insufficient public price history to evaluate earnings stability.

Definitive Healthcare Corp. has positive free cash flow, indicating the company generates cash after capital expenditures

Definitive Healthcare Corp. has a free cash flow yield of 50.27%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Definitive Healthcare Corp.'s yearly earnings has increased -66.37% since last year from $-413.12M to $-138.93M, signaling increasing performance

Definitive Healthcare Corp.'s yearly revenue has decreased 4.24% since last year from $252.20M to $241.52M, signaling decreasing performance

ROIC 41.86% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Definitive Healthcare Corp.'s 3-year revenue CAGR of 2.75% is positive, indicating growing revenue over the past 3 years

Definitive Healthcare Corp. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Definitive Healthcare Corp. has insufficient public price history to evaluate ROE consistency.

Definitive Healthcare Corp. is undervalued relative to its fair value price of 6.17 based on Discounted Cash Flow model

Definitive Healthcare Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Definitive Healthcare Corp. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Definitive Healthcare Corp. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Definitive Healthcare Corp. has insufficient data to evaluate this check.

Definitive Healthcare Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Definitive Healthcare Corp. has a price-to-book ratio of 0.39x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Definitive Healthcare Corp. has a price-to-sales ratio of 0.32x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue